Edge Rewrite
restyle Source code View original
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

4-AcO-MPT

Add links
From Wikipedia, the free encyclopedia
(Redirected from 4-Acetoxy-MPT)

4-AcO-MPT
Clinical data
Other names4-Acetoxy-MPT; 4-Acetoxy-N-methyl-N-propyltryptamine
Routes of
administration		Oral
Drug classNon-selective serotonin receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Identifiers
  • [3-[2-[methyl(propyl)amino]ethyl]-1H-indol-4-yl] acetate
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC16H22N2O2
Molar mass274.364 g·mol−1
3D model (JSmol)
  • CCCN(C)CCC1=CNC2=C1C(=CC=C2)OC(=O)C
  • InChI=1S/C16H22N2O2/c1-4-9-18(3)10-8-13-11-17-14-6-5-7-15(16(13)14)20-12(2)19/h5-7,11,17H,4,8-10H2,1-3H3
  • Key:CECCEKYTLKWWJJ-UHFFFAOYSA-N

4-AcO-MPT, also known as 4-acetoxy-N-methyl-N-propyltryptamine, is a psychedelic drug of the tryptamine and 4-hydroxytryptamine families related to 4-AcO-DMT (psilacetin).[1][2][3][4][5]

Use and effects

[edit]

Interactions

[edit]

Pharmacology

[edit]

Pharmacodynamics

[edit]

4-AcO-MPT is thought to act as a prodrug of 4-HO-MPT and hence is believed to act as a non-selective serotonin receptor agonist including of the serotonin 5-HT2A receptor.[3][4] The receptor interactions of 4-AcO-MPT have been studied.[6] The drug produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents,[4]

Chemistry

[edit]

Analogues

[edit]

Analogues of 4-AcO-MPT include methylpropyltryptamine (MPT), 4-HO-MPT (meprocin), 5-MeO-MPT, 4-AcO-DMT (psilacetin), 4-AcO-MET (metacetin), 4-AcO-MiPT (mipracetin), and 4-AcO-DPT (depracetin), among others.

History

[edit]

4-AcO-MPT was first described in the scientific literature by at least 2017.[2] It was first encountered as a novel designer drug in 2018.[1]

Society and culture

[edit]
[edit]

Canada

[edit]

4-AcO-MPT is not a controlled substance in Canada as of 2025.[7]

Sweden

[edit]

4-AcO-MPT is a controlled substance in Sweden.[8]

See also

[edit]

References

[edit]
  1. 1 2 "4-AcO-MPT". АИПСИН (in Russian). Retrieved 11 October 2025.
  2. 1 2 Chapman S (31 December 2017). PeakAL: Protons I Have Known and Loved, Too — Another Fifty Shades of Grey-Market Spectra (PDF) (Report). doi:10.16889/isomerdesign-5. Retrieved 11 October 2025.
  3. 1 2 Berardinelli D, Montanari E, Malaca S, Zaami S, Busardò FP, Huestis MA, et al. (2022). "4-Hydroxy-N,N-methylpropyltryptamine (4-OH-MPT) in vitro human metabolism". Toxicologie Analytique et Clinique. 34 (3): S96. Bibcode:2022ToxAC..34Q..96B. doi:10.1016/j.toxac.2022.06.147.
  4. 1 2 3 Klein AK, Chatha M, Laskowski LJ, Anderson EI, Brandt SD, Chapman SJ, et al. (April 2021). "Investigation of the Structure-Activity Relationships of Psilocybin Analogues". ACS Pharmacology & Translational Science. 4 (2): 533–542. doi:10.1021/acsptsci.0c00176. PMC 8033608. PMID 33860183.
  5. ↑ Glatfelter GC, Naeem M, Pham DN, Golen JA, Chadeayne AR, Manke DR, et al. (April 2023). "Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-N,N-dimethyltryptamine in Mice". ACS Pharmacology & Translational Science. 6 (4): 567–577. doi:10.1021/acsptsci.2c00222. PMC 10111620. PMID 37082754.
  6. ↑ Glatfelter GC, Naeem M, Pham DN, Golen JA, Chadeayne AR, Manke DR, et al. (April 2023). "Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-N,N-dimethyltryptamine in Mice". ACS Pharmacol Transl Sci. 6 (4): 567–577. doi:10.1021/acsptsci.2c00222. PMC 10111620. PMID 37082754.
  7. ↑ "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
  8. ↑ "4-AcO-MPT". АИПСИН (in Russian). Retrieved 2 January 2026.
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=4-AcO-MPT&oldid=1348444246"